Comparison of the Efficacy of Dextrose Prolotherapy and Mesotherapy in Lateral Epicondylitis (NCT06538194) | Clinical Trial Compass
CompletedNot Applicable
Comparison of the Efficacy of Dextrose Prolotherapy and Mesotherapy in Lateral Epicondylitis
Turkey (Türkiye)84 participantsStarted 2024-04-01
Plain-language summary
A total of 84 patients with lateral epicondylitis were included in the study. The patients were randomly assigned to 3 treatment groups: mesotherapy (n = 28), prolotherapy (n = 28), and control (n = 28). Patients were evaluated before treatment and at the 3rd and 8th weeks of treatment for pain severity measured with the Visual Activity Scale (VAS) during resting, activity, and at night, and for functional status with a short version of the upper limb-specific disabilities of the arms, shoulder, and hand (Quick-Dash) and Oxford Elbow Score.
Who can participate
Age range
20 Years – 60 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Elbow pain for at least three months. Pain around the lateral epicondyle during resisted extension of wrist and fingers Tenderness over the lateral epicondyle
Exclusion Criteria:
* Recent upper-extremity surgery,
* Recent upper extremity trauma, fracture, or dislocation,
* Upper-extremity peripheral neuropathy,
* Infectious processes of joint or soft tissues of the upper extremity
* Decompensated heart or respiratory failure
* Rheumatologic Diseases
* Psychiatric Disorders
* History of allergy to ingredients of injection solution
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
VAS
Timeframe: All measures were conducted at baseline, after treatment, at 3th and 8th weeks follow-ups.
2
short version of the upper limb-specific Disabilities of Arms, Shoulder and Hand (Quick-Dash)
Timeframe: All measures were conducted at baseline, after treatment, at 3th and 8th weeks follow-ups.
3
Oxford Elbow Score
Timeframe: All measures were conducted at baseline, after treatment, at 3th and 8th weeks follow-ups.
Trial details
NCT IDNCT06538194
SponsorHaydarpasa Numune Training and Research Hospital